Using a lab model, Stanford researchers identified a type of developing brain cell that is profoundly changed by exposure to low oxygen levels.
Stanford scientists and collaborators have harnessed CRISPR to replace the mutated gene underpinning the devastating immune disease, SCID-X1.
This In the Spotlight features Kyle Loh, a stem cell researcher who is working to create pure populations of cells. He also enjoys road bicycling.
Antibody-based hematopoietic stem cell transplants may transform the treatment of patients with blood and immune diseases including cancers.
A team of researchers have found a new way to remove blood-producing stem cells, introducing the possibility of safer, and non-matched, transplants.
Honeybee royal jelly affects the developmental potential of mouse stem cells. A structurally similar protein in mammals could aid stem cell research.
Is extensive regeneration possible in humans? Stanford researchers show skeletal stem cells can move backward developmentally when major repairs are needed.
Stanford scientists identified two key genes responsible for the rapid bone growth of deer antlers, a finding that may one day help treat bone disease.
'Mitotic catastrophe' hampers the ability of aged muscle stem cells to repair damage. Manipulating this process could lead to new therapies for old muscle.
Discovery of the human skeletal stem cell opens the way to regenerate cartilage and bone to repair damaged tissues, say Stanford scientists.
A profile by The Scientist of Lucy Shapiro, PhD, highlights her career and the passions that guided her groundbreaking scientific research.
Stanford researchers identify a new protein that can fully substitute for one of the key "Yamanaka factors" to reprogram adult stem cells.
Blood cells to neurons in just three weeks? Stanford researchers pull off an amazing biological transformation that could transform research into neurological disorders such as schizophrenia and autism.
Mimicking a stem cells' natural environment in the laboratory is impossible without recent bioengineering advances. Stanford scientists reflect on the field and speculate about future possibilities, including growing whole organs.
Protein aggregates in young neural stem cells seem to echo those seen in neurodegenerative disease-- but could they actually be helpful? As the cells age, they become less able to process the aggregates and their ability to activate is dampened.
Reaping stem cells’ full therapeutic benefits requires a detailed understanding of the complex relationships between the cells and their environments -- whether in a lab dish or a patient’s body.
